EQUINOX NEPREMICNINE d.d. (LJSE: EQNX)

EQUINOX NEPREMICNINE d.d. Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Rental Revenue	7.45	7.15	6.51	5.98
Other Revenue	1.04	0.63	0.84	0.73
Total Revenue	8.5	7.79	7.34	6.71
Revenue Growth (YoY	11.56%	6.03%	9.38%	-
Property Expenses	2.03	1.62	2.42	2.08
Depreciation & Amortization	3.89	3.76	3.41	3.43
Other Operating Expenses	2.12	2.04	0.11	0.76
Total Operating Expenses	8.04	7.42	5.94	6.27
Operating Income	0.45	0.37	1.4	0.45
Interest Expense	-0.6	-0.64	-0.85	-0.33
Interest & Investment Income	1.71	1.24	0.3	0.19
Other Non-Operating Income	-0.01	0	0	0.07
EBT Excluding Unusual Items	1.55	0.97	0.85	0.38
Pretax Income	1.55	0.97	0.85	0.38
Income Tax Expense	0.27	0.1	0.14	-0.16
Net Income	1.28	0.87	0.71	0.54
Net Income to Common	1.28	0.87	0.71	0.54
Net Income Growth	132.99%	22.07%	31.87%	-
Basic Shares Outstanding	2	2	2	-
Diluted Shares Outstanding	2	2	2	-
EPS (Basic)	0.71	0.48	0.40	-
EPS (Diluted)	0.71	0.48	0.40	-
EPS Growth	-	22.07%	-	-
Dividend Per Share	-	1.690	1.430	-
Dividend Growth	-	18.18%	-	-
Operating Margin	5.31%	4.72%	19.11%	6.68%
Profit Margin	15.03%	11.16%	9.69%	8.04%
Free Cash Flow Margin	-	73.24%	112.86%	221.39%
EBITDA	4.48	4.13	4.81	3.88
EBITDA Margin	52.73%	53.05%	65.54%	57.83%
D&A For Ebitda	4.03	3.76	3.41	3.43
EBIT	0.45	0.37	1.4	0.45
EBIT Margin	5.31%	4.72%	19.11%	6.68%
Effective Tax Rate	17.60%	10.49%	16.20%	-
Revenue as Reported	7.79	7.79	7.34	-

Source: S&P Capital IQ. Real Estate template. Financial Sources.